These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31178469)

  • 21. Advances in cell-based therapy for peripheral vascular disease.
    Blum A; Balkan W; Hare JM
    Atherosclerosis; 2012 Aug; 223(2):269-77. PubMed ID: 22494624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA).
    Walter DH; Krankenberg H; Balzer JO; Kalka C; Baumgartner I; Schlüter M; Tonn T; Seeger F; Dimmeler S; Lindhoff-Last E; Zeiher AM;
    Circ Cardiovasc Interv; 2011 Feb; 4(1):26-37. PubMed ID: 21205939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.
    Henry TD; Pepine CJ; Lambert CR; Traverse JH; Schatz R; Costa M; Povsic TJ; David Anderson R; Willerson JT; Kesten S; Perin EC
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):169-177. PubMed ID: 27148802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Angiogenesis Using Autologous CD34-Positive Cells for Vascular Diseases.
    Fujita Y; Kawamoto A
    Ann Vasc Dis; 2022 Dec; 15(4):241-252. PubMed ID: 36644256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial progenitor cells: regulation and contribution to adult neovascularization.
    Walter DH; Dimmeler S
    Herz; 2002 Nov; 27(7):579-88. PubMed ID: 12439630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study.
    Povsic TJ; Junge C; Nada A; Schatz RA; Harrington RA; Davidson CJ; Fortuin FD; Kereiakes DJ; Mendelsohn FO; Sherman W; Schaer GL; White CJ; Stewart D; Story K; Losordo DW; Henry TD
    Am Heart J; 2013 Jun; 165(6):854-861.e2. PubMed ID: 23708155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endothelial progenitor cells: role in endothelial function recovery and potential therapeutic application].
    Ruda MM; Parfenova EV; Karpov IuA
    Kardiologiia; 2008; 48(1):66-73. PubMed ID: 18260999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic cellular angiogenesis in treatment of peripheral artery diseases].
    Khorev NG; Elykomov VA; Zaloznyĭ DA
    Angiol Sosud Khir; 2011; 17(2):36-44. PubMed ID: 21983460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD31+ Cells From Peripheral Blood Facilitate Bone Regeneration in Biologically Impaired Conditions Through Combined Effects on Immunomodulation and Angiogenesis.
    Sass FA; Schmidt-Bleek K; Ellinghaus A; Filter S; Rose A; Preininger B; Reinke S; Geissler S; Volk HD; Duda GN; Dienelt A
    J Bone Miner Res; 2017 May; 32(5):902-912. PubMed ID: 27976803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenic CD34 Stem Cell Therapy in Coronary Microvascular Repair-A Systematic Review.
    Rai B; Shukla J; Henry TD; Quesada O
    Cells; 2021 May; 10(5):. PubMed ID: 34066713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases.
    Lee JH; Lee SH; Yoo SY; Asahara T; Kwon SM
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1622-34. PubMed ID: 23640491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of peripheral arterial disease using stem and progenitor cell therapy.
    Lawall H; Bramlage P; Amann B
    J Vasc Surg; 2011 Feb; 53(2):445-53. PubMed ID: 21030198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation of CD34+ cells for myocardial ischemia.
    Matta A; Nader V; Galinier M; Roncalli J
    World J Transplant; 2021 May; 11(5):138-146. PubMed ID: 34046316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy.
    Bianconi V; Sahebkar A; Kovanen P; Bagaglia F; Ricciuti B; Calabrò P; Patti G; Pirro M
    Pharmacol Ther; 2018 Jan; 181():156-168. PubMed ID: 28827151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.
    Kawamoto A; Katayama M; Handa N; Kinoshita M; Takano H; Horii M; Sadamoto K; Yokoyama A; Yamanaka T; Onodera R; Kuroda A; Baba R; Kaneko Y; Tsukie T; Kurimoto Y; Okada Y; Kihara Y; Morioka S; Fukushima M; Asahara T
    Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current State of Stem Cell Therapy for Ischemic Heart Disease.
    Povsic TJ
    Curr Cardiol Rep; 2016 Feb; 18(2):17. PubMed ID: 26768743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow stem cells for the treatment of ischemic heart disease: a clinical trial review.
    Fuh E; Brinton TJ
    J Cardiovasc Transl Res; 2009 Jun; 2(2):202-18. PubMed ID: 20559989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of Nitric Oxide Synthase Restores Circulating Angiogenic Cell Function in Patients With Coronary Artery Disease: Implications for Autologous Cell Therapy for Myocardial Infarction.
    Chen Q; Varga M; Wang X; Haddad DJ; An S; Medzikovic L; Derakhshandeh R; Kostyushev DS; Zhang Y; Clifford BT; Luu E; Danforth OM; Rafikov R; Gong W; Black SM; Suchkov SV; Fineman JR; Heiss C; Aschbacher K; Yeghiazarians Y; Springer ML
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selected CD133⁺ progenitor cells to promote angiogenesis in patients with refractory angina: final results of the PROGENITOR randomized trial.
    Jimenez-Quevedo P; Gonzalez-Ferrer JJ; Sabate M; Garcia-Moll X; Delgado-Bolton R; Llorente L; Bernardo E; Ortega-Pozzi A; Hernandez-Antolin R; Alfonso F; Gonzalo N; Escaned J; Bañuelos C; Regueiro A; Marin P; Fernandez-Ortiz A; Neves BD; Del Trigo M; Fernandez C; Tejerina T; Redondo S; Garcia E; Macaya C
    Circ Res; 2014 Nov; 115(11):950-60. PubMed ID: 25231095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of ex vivo produced endothelial progenitor cells for autologous transplantation in primates.
    Qin M; Guan X; Zhang Y; Shen B; Liu F; Zhang Q; Ma Y; Jiang Y
    Stem Cell Res Ther; 2018 Jan; 9(1):14. PubMed ID: 29357928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.